The global Fluorescent Immunoassay Market was valued at US$ 2,578.66 million in 2021 and is projected to reach US$ 3,778.78 million by 2028; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.
The growth of the global fluorescent immunoassay market is mainly attributed to factors such as growing prevalence of chronic diseases worldwide and increasing demand for cell therapies. However, the global fluorescent immunoassay market is likely to get impacted by the disadvantages of fluorescent immunoassays during the forecast period.
Get a Sample PDF of report at: https://www.premiummarketinsights.com/sample/TIP00073488
The List of Companies – Fluorescent Immunoassay Market
- Thermo Fisher Scientific
- Abbott Laboratories
- Ortho Clinical Diagnostics
- Hoffmann La Roche
- bioM?rieux SA
- Siemens AG
- Quidel Corporation
Based on product type, the global fluorescent immunoassay market is segmented into ELISA, rapid lateral flow immunoassay, and others. In 2021, the ELISA segment accounted for the largest share of the market. ELISA is a plate-based test technique for detecting and measuring soluble molecules such as peptides, proteins, antibodies, and hormones. The growth of this segment is attributed to the significant use of immunoassay tests to diagnose cancer, infectious illnesses, and other chronic problems. The same segment is likely to register the highest CAGR in the global fluorescent immunoassay market during the forecast period.
Fluorescent immunoassays are simply a different type of immunoassay. The critical variable is the biochemical technique used to detect the binding of the “detector” antibody and the analyte molecule. Fluorescent immunoassay is a sensitive technique that can measure many compounds, including drugs, hormones, and proteins; identify antibodies; and quantify antigens such as viral particles and possibly bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. Several breakthroughs have been made in recent years that have enabled a fluorescence-based immunoassay system at the point of care. Several technical improvements have recently occurred that have allowed a susceptible immunoassay system to implement. These include the availability of narrow-wavelength, low-cost light sources, newer, more stable fluorophores with extensive Stokes shifts, stable solid-state light detectors, and microprocessors to process and analyze the data from each test. When a fluorescence detection system is connected to a lateral flow assay and combined with a powerful yet inexpensive analyzer, the result is improved assay performance.
Buy a copy of this research report at @: https://www.premiummarketinsights.com/buy/TIP00073488
Ever since severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was declared a public health emergency of international concern in late January 2020, medical professionals and researchers have been feeling the need for comprehensive and rapid testing of citizens to plan measures that can contain the spread of the virus. Over time, real-time PCR tests and antibody tests have emerged as vital techniques for the global healthcare system to manage the outbreak. Fluorescent immunoassay is essential for differential diagnosis of SARS-CoV-2. It is a test performed by patient serum or plasma with red reagent cells. Determination of specific antibodies to viral and bacterial pathogens and parasites facilitates the correct therapeutic measures. Fluorescent immunoassay is critical for implementing an effective and efficient public health strategy to minimize the adverse impact of the COVID-19 pandemic. It should be adopted for important clinical utility cases and support return-to-work strategy globally.
TABLE OF CONTENTS
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 By Product Type
1.3.2 By Application
1.3.3 By End User
1.3.4 By Geography
- Key Takeaways
- Research Methodology
3.2 Secondary Research
3.3 Primary Research
- Market Landscape
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America- PEST Analysis
4.3 Expert Opinions
- Key Market Dynamics
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost-effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
Premium Market Insights has an extensive coverage of industry reports, company reports and country reports across all industries. In case your research needs are not met by syndicated reports offered by leading publishers, we can help you by offering a customized research solution by liaising with different research agencies saving your valuable time and money.
We provide best in class customer service and our customer support team is always available to help you on your research queries. Our commitment to customer service is best exemplified by free analyst support that we offer to our clients which sets us apart from any other provider. We also offer enterprise subscriptions which provide significant cost savings to our clients.
If you have any queries about this report or if you would like further information, please
Contact Person: Sameer Joshi
Email: [email protected]